P9 N-actylcysteine fails to impact on plasma antioxidant status in a placebo controlled crossover study in healthy volunteers and patients with chronic kidney disease: implications for its value in preventing contrast-induced nephropathy

Abstract

IntroductionN-acetyl-l-cysteine (NAC) has been proposed as a prophylactic for the prevention of contrast induced nephropathy (CIN), a severe, undesirable consequence following angiography that accounts for ∼12% of all hospital-acquired acute...